Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
JAMA Ophthalmology|September 9, 2016
Prevalence of Noninfectious Uveitis in the United States: A Claims-Based AnalysisJennifer E Thorne, Eric Suhler, Martha Skup, et al.Current Medical Research and Opinion|November 22, 2013
Real-world adherence and persistence associated with nebivolol or hydrochlorothiazide as add-on treatment for hypertensionStephanie Chen, Dendy Macaulay, Elyse Swallow, et al.Rheumatology and Therapy|April 26, 2021
Higher Medication Adherence and Lower Opioid Use Among Individuals with Autoimmune Disease Enrolled in an Adalimumab Patient Support Program in the United StatesA Mark Fendrick, Dendy Macaulay, Debbie Goldschmidt, et al.Journal of Medical Economics|September 8, 2017
Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured populationSusanne X Wang, Arijit X Ganguli, Amit Bodhani, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 28, 2018
The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United StatesPablo Martinez-Martin, Dendy Macaulay, Yash J Jalundhwala, et al.Clinical and Experimental Gastroenterology|December 21, 2018
Incidence of catheter-related complications among Japanese patients with central venous catheters as well as patients with short bowel syndromeVicki K Wing, Yan Song, Cheryl Xiang, et al.Pharmacoeconomics|July 14, 2012
Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescentsVanja Sikirica, M Haim Erder, Jipan Xie, et al.Crohn'S & Colitis 360|February 13, 2023
Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or VedolizumabMichael Chiorean, Anita Afzali, Raymond K Cross, et al.Advances in Therapy|April 1, 2019
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data AnalysisZhou Zhou, Yanni Fan, Darren Thomason, et al.Current Medical Research and Opinion|March 18, 2016
Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United StatesWilliam J Sandborn, Atsushi Sakuraba, Anthony Wang, et al.Pageof 3